Scripps Research is pioneering a new model for nonprofit research institutes to address the significant health challenges facing humanity in the 21st century, from pandemic threats to the aging of the global population. Founded 100 years ago, Scripps Research is renowned in the life sciences and chemistry for scientific excellence and for training the scientific leaders of tomorrow.
Building on this solid foundation, we have established a unique model that seamlessly combines world-class fundamental and translational research to accelerate the development of innovative, new medicines. We believe this model best captures the impact of groundbreaking discoveries for the benefit of human health.
Moreover, revenues generated from these new medicines are reinvested into research, creating a self-renewing funding source and business model that amplifies investments in science and their ultimate impact on the public.
Scripps Research
By 2050, approximately 40% of the U.S. population will be age 65 or older. While increased lifespan is encouraging, the societal challenges are becoming more apparent: Chronic diseases are overwhelming the ability of families, government agencies and healthcare providers to provide care and pay for medical costs.
In response to this growing crisis, Scripps Research scientists have made major advances in deciphering biological underpinnings of aging and developing a new generation of experimental medicines to prevent, treat and manage chronic age-related disease. Learn more in our latest animated video.
1 day ago | [YT] | 2
View 0 replies
Scripps Research
Researchers are studying antibodies from recovered COVID-19 patients, hoping to use them to develop treatments and vaccines. One treatment possibility is convalescent plasma illustrated here in a scene from the latest installment of our Science, Simplified series. See more: https://youtu.be/3pFQpiawX80
5 years ago | [YT] | 2
View 0 replies
Scripps Research
Antibodies can block the novel coronavirus from attaching to your cells. Scientists are studying antibodies from recovered patients, hoping to use them to develop treatments and vaccines. Learn more in the latest installment of our Science, Simplified series - https://youtu.be/3pFQpiawX80
5 years ago | [YT] | 3
View 0 replies
Scripps Research
Have you checked out the latest installment of our Science, Simplified series? We're using incredible illustrations from graduate student researcher Hailee Perrett to explain basic coronavirus concepts. In this video, we show you how antibodies neutralize the virus, and how researchers might be able to turn them into treatments or vaccines.
5 years ago | [YT] | 1
View 0 replies